Activity of β-lactam antimicrobial agents against clinical isolates of Bacteroides fragilis in Kuwait

Clinical Microbiology and Infection

Volumn 4, Issue 12, 1998, Pages 728-730

  Rotimi, Vincent O ^a   Khodakhast, Fatma B ^a   Jamal, Wafaa Y ^a   Mokaddas, Eiman M ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b IBN SINA HOSPITAL   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; HUMAN; KUWAIT; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS;

EID: 0032435206     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00660.x     Document Type: Review

References (10)

1. Finegold SM, the National Committee for Clinical Laboratory Standards Working Group on Anaerobic Susceptibility Testing. Susceptibility testing of anaerobic bacteria. J Clin Microbiol 1988; 26: 1253-6.
2. Finegold SM. Anaerobes; problems and controversies in bacteriology, infections, and susceptibility testing. Rev Infect Dis 1990; 12: 233-40.
3. Tally FP, Cuchural GJ Jr, Jacobus NV, et al. Susceptibility of Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother 1983; 23: 536-40.
4. Tally FP, Cuchural GC Jr, Jacobus NV, et al. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother 1985; 28: 675-7.
5. Garcia-Rodriguez JE, Garcia-Sanchez JE. Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain. Rev Infect Dis 1990; 12: 142-51.
6. Dubreuil L, Devos J, Neut C, Romond C. Susceptibility of anaerobic bacteria from several hospitals to three major antibiotics. Antimicrob Agents Chemother 1984; 25: 764-6.
7. Watanabe K, Ueno K, Kato N, et al. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaitaomicron in Japan. Eur J Clin Microbiol Infect Dis 1992; 11: 1069-73.
8. Ohm-Smith M. Agar dilution test for anaerobic bacteria. In Isenberg HD, ed. Clinical microbiology procedures handbook, Vol. 1. Washington DC: American Society for Microbiology, 1992: 591.
9. National Committee for Clinical Laboratory Standards. Method for antimicrobial susceptibility testing of anaerobic bacteria. Approved Standard M11-A3. Villanova: NCCLS, 1993.
10. Jacobs MR, Spangler SK, Appelbaum PC. Beta-lactamase production and susceptibility of US and European anaerobic Gram-negative bacilli to beta-lactams and other agents. Eur J Clin Microbiol Infect Dis 1992; 11: 1081-93.